Source: International Congress 2018 – State of the art session: Airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Singh (Manchester, United Kingdom). Eosinophils in COPD: do they predict drug response?. International Congress 2018 – State of the art session: Airways disease

Member's Comments

No comment yet.

Related content which might interest you: Targeting neutrophils in asthma: a strategy shared with COPD? Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma? Year: 2012 Neutrophils, airway hyperresponsiveness and COPD: true, true and related? Source: Eur Respir J 2012; 40: 1067-1069 Year: 2012 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010 Eosinophils: a biological marker for bronchiectasis exacerbations? Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 COPD treatment choices based on blood eosinophils: are we there yet? Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019 Year: 2019 Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients? Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Response to ß2-mimetics in asthmatic children: Which lung function parameters present reliable response? Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Bronchiectasis in COPD: increased susceptibility of the airways to aggressive agents? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019